Return to homepagePandemic Pact

to identify and develop alternative biologics for the prevention and treatment of COVID-19 for low and middle income countries

Grant number: INV-035430

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Known Financial Commitments (USD)

    $18,066,005

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    International AIDS Vaccine Initiative Inc

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Scalable Production of a De Novo SARS-CoV-2 Antiviral miniprotein in E scherichia coli